Aurinia Pharmaceuticals
AUPH
#4603
Rank
A$3.12 B
Marketcap
A$23.67
Share price
0.38%
Change (1 day)
65.89%
Change (1 year)

Aurinia Pharmaceuticals (AUPH) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.24 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aurinia Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.27 B11.5%
2023-12-31A$0.24 B159.7%
2022-12-31A$96.14 M8.44%
2021-12-31A$88.65 M21.93%
2020-12-31A$72.71 M98.08%
2019-12-31A$36.7 M-22.31%
2018-12-31A$47.25 M53.04%
2017-12-31A$30.87 M5.74%
2016-12-31A$29.19 M56.36%
2015-12-31A$18.67 M-17.42%
2014-12-31A$22.61 M104.7%
2013-12-31A$11.04 M82.92%
2012-12-31A$6.03 M-21.71%
2011-12-31A$7.71 M99.17%
2010-12-31A$3.87 M-26.58%
2009-12-31A$5.27 M-80.19%
2008-12-31A$26.63 M63.36%
2007-12-31A$16.3 M22.74%
2006-12-31A$13.28 M-18.96%
2005-12-31A$16.38 M41.35%
2004-12-31A$11.59 M46.31%
2003-12-31A$7.92 M43.11%
2002-12-31A$5.53 M58.82%
2001-12-31A$3.48 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Regeneron Pharmaceuticals
REGN
A$13.90 B 5,594.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
A$35.94 M-85.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
A$6.42 M-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA